product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
Integrin beta 1/CD29 Antibody (P4C10) - BSA Free
catalog :
NBP2-36561
quantity :
0.1 ml (also 0.025 ml)
price :
379 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
P4C10
reactivity :
human, mouse
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry, neutralization, immunoprecipitation, flow cytometry, immunohistochemistry - frozen section
more info or order :
citations: 28
Reference
Xing Y, Li X, Lu S, Ma J. Regulation of opticin on bioactivity of retinal vascular endothelial cells cultured in collagen. Int J Ophthalmol. 2020;13:1202-1209 pubmed publisher
Zhang Z, Hu P, Wang Z, Qiu X, Chen Y. BDNF promoted osteoblast migration and fracture healing by up-regulating integrin β1 via TrkB-mediated ERK1/2 and AKT signalling. J Cell Mol Med. 2020;24:10792-10802 pubmed publisher
Oppel F, Ki D, Zimmermann M, Ross K, Tao T, Shi H, et al. suz12 inactivation in p53 and nf1 deficient zebrafish accelerates the onset of MPNSTs and expands the spectrum of tumor types to include adenocarcinoma, leukemia, and soft tissue sarcoma. Dis Model Mech. 2020;: pubmed publisher
Liu Z, Murphy S, Huang J, Zhao L, Hall C, Schaeffer A, et al. A novel immunocompetent model of metastatic prostate cancer-induced bone pain. Prostate. 2020;80:782-794 pubmed publisher
Estermann M, Williams S, Hirst C, Roly Z, Serralbo O, Adhikari D, et al. Insights into Gonadal Sex Differentiation Provided by Single-Cell Transcriptomics in the Chicken Embryo. Cell Rep. 2020;31:107491 pubmed publisher
Fukushima K, Satoh T, Sugihara F, Sato Y, Okamoto T, Mitsui Y, et al. Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis. Immunity. 2020;52:542-556.e13 pubmed publisher
Dey P, Li J, Zhang J, Chaurasiya S, Strom A, Wang H, et al. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment. Cancer Discov. 2020;10:608-625 pubmed publisher
Roly Z, Major A, Fulcher A, Estermann M, Hirst C, Smith C. Adhesion G-protein-coupled receptor, GPR56, is required for Müllerian duct development in the chick. J Endocrinol. 2020;244:395-413 pubmed publisher
Oppel F, Tao T, Shi H, Ross K, Zimmerman M, He S, et al. Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies. PLoS Genet. 2019;15:e1008039 pubmed publisher
Wan J, Block S, Scribano C, Thiry R, Esbona K, Audhya A, et al. Mad1 destabilizes p53 by preventing PML from sequestering MDM2. Nat Commun. 2019;10:1540 pubmed publisher
JENSEN T, Wanczyk H, Sharma I, Mitchell A, Sayej W, Finck C. Polyurethane scaffolds seeded with autologous cells can regenerate long esophageal gaps: An esophageal atresia treatment model. J Pediatr Surg. 2018;: pubmed publisher
Ijsselsteijn M, Brouwer T, Abdulrahman Z, Reidy E, Ramalheiro A, Heeren A, et al. Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification. J Pathol Clin Res. 2019;5:3-11 pubmed publisher
Shen L, Ke Q, Chai J, Zhang C, Qiu L, Peng F, et al. PAG1 promotes the inherent radioresistance of laryngeal cancer cells via activation of STAT3. Exp Cell Res. 2018;370:127-136 pubmed publisher
Li S, Xiong N, Peng Y, Tang K, Bai H, Lv X, et al. Acidic pHe regulates cytoskeletal dynamics through conformational integrin ?1 activation and promotes membrane protrusion. Biochim Biophys Acta Mol Basis Dis. 2018;1864:2395-2408 pubmed publisher
Cho C, Kang H, Ryu Y, Park Y, Jeong H, Park Y, et al. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype. Gastric Cancer. 2018;21:925-935 pubmed publisher
Pinnington S, Marshall J, Wheeler A. Correlative 3D Structured Illumination Microscopy and Single-Molecule Localization Microscopy for Imaging Cancer Invasion. Methods Mol Biol. 2018;1764:253-265 pubmed publisher
Banco B, Ferrari R, Stefanello D, Groppetti D, Pecile A, Faverzani S, et al. Ovarian Embryonal Carcinoma in a Dog. J Comp Pathol. 2017;157:291-295 pubmed publisher
Fan D, Takawale A, Shen M, Samokhvalov V, Basu R, Patel V, et al. A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin ?1. Hypertension. 2016;68:937-48 pubmed publisher
Ordonez N. Broad-spectrum immunohistochemical epithelial markers: a review. Hum Pathol. 2013;44:1195-215 pubmed publisher
Beauséjour M, Noël D, Thibodeau S, Bouchard V, Harnois C, Beaulieu J, et al. Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes. Apoptosis. 2012;17:566-78 pubmed publisher
Niikura H, Okamoto S, Yoshinaga K, Nagase S, Takano T, Ito K, et al. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol. 2007;105:683-6 pubmed
Berg A, Berner A, Lilleby W, Bruland Ø, Fossa S, Nesland J, et al. Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy. Int J Cancer. 2007;120:1603-9 pubmed
Azumi M, Saga Y, Hashimoto H, Kakizaki H. [Histological investigation of prostate cancer treated with hormonal agents]. Hinyokika Kiyo. 2006;52:781-4 pubmed
Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, et al. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004;10:5342-8 pubmed
Alexander Sefre F, Singh N, Ayhan A, Thomas J, Jacobs I. Assessment of the depth of myometrial invasion in stage I endometrioid endometrial cancer using pancytokeratin immunohistochemistry. Int J Gynecol Cancer. 2004;14:665-72 pubmed
Krishnamurthy S, Sneige N, Ordonez N, Hunt K, Kuerer H. Characterization of foam cells in nipple aspirate fluid. Diagn Cytopathol. 2002;27:261-4; discussion 265 pubmed
Alibardi L, Maurizii M, Taddei C. Immunocytochemical and electrophoretic distribution of cytokeratins in the resting stage epidermis of the lizard Podarcis sicula. J Exp Zool. 2001;289:409-18 pubmed
Li E, Brown S, Stupack D, Puente X, Cheresh D, Nemerow G. Integrin alpha(v)beta1 is an adenovirus coreceptor. J Virol. 2001;75:5405-9 pubmed
product information
brand :
Novus
master code :
NBP2-36561
SKU :
NBP2-36561
product name :
Integrin beta 1/CD29 Antibody (P4C10) - BSA Free
description :
The Integrin beta 1/CD29 Antibody (P4C10) - BSA Free from Novus Biologicals is a mouse monoclonal antibody to Integrin beta 1/CD29. This antibody reacts with human, mouse. The Integrin beta 1/CD29 Antibody (P4C10) - BSA Free has been validated for the following applications: Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Frozen, Block/Neutralize.
target :
Integrin beta 1/CD29
category :
Primary Antibodies
sizes available :
0.1 ml (also 0.025 ml)
buffer :
PBS
clonality :
Monoclonal
clone :
P4C10
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
HT1080 cells human fibrosarcoma
isotype :
IgG1
purity :
Protein G purified
species :
Human, Mouse
specificity :
Reacts with human Integrin beta 1
theoretical molecular weight :
88 kDa
gene symbol :
ITGB1
accessionNumbers :
P05556
applications :
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Frozen, Block/Neutralize
USD :
377
USD 2023 :
379 USD
alt names :
CD29, CD29 antigen, Fibronectin receptor subunit beta, FNRBVLAB, GPIIA, integrin beta-1, integrin VLA-4 beta subunit, integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includesMDF2, MSK12), MDF2, MSK12, very late activation protein, beta polypeptide, VLA-4 subunit beta, VLA-BETA
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.